Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06602960Not ApplicableTerminated

Nextsense Brain-sensing Buds Study

Role: lead

NCT05066009Not ApplicableCompleted

Sleep/Wake State Assessment with Non-invasive Earbuds

Role: collaborator

NCT05114616Not ApplicableCompleted

Assessment of Consciousness States with NextSense Ear Bud Devices

Role: collaborator

NCT05257811Completed

Earbud EEG Feasibility Study

Role: lead

All 4 trials loaded